| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA840412 | A | Area under curve for plasma concentration after peroral administration at dose of 100 mg/kg for 1 day in rats | Rattus norvegicus | 1 | organism-based format | Scientific Literature | ||
| 2. | ALA840414 | A | Area under curve for plasma concentration after peroral administration at dose of 100 mg/kg for 7 days in rats | Rattus norvegicus | 1 | organism-based format | Scientific Literature | ||
| 3. | ALA839557 | A | Area under curve for plasma concentration after peroral administration at dose of 80 mg/kg for 10 days in mouse | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 4. | ALA840429 | A | Area under curve or plasma concentration after intravenous administration at dose of 80 mg/kg for 10 days in mouse | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 5. | ALA838436 | A | Maximum plasma concentration of compound after peroral administration at dose of 100 mg/kg for 1 days in rats | Rattus norvegicus | 1 | organism-based format | Scientific Literature | ||
| 6. | ALA838437 | A | Maximum plasma concentration of compound after peroral administration at dose of 100 mg/kg for 7 days in rats | Rattus norvegicus | 1 | organism-based format | Scientific Literature | ||
| 7. | ALA838439 | A | Maximum plasma concentration of compound after peroral administration at dose of 80 mg/kg for 10 days in mouse | Mus musculus | 2 | organism-based format | Scientific Literature | ||
| 8. | ALA838748 | A | Maximum plasma concentration of compound after intravenous administration at dose of 80 mg/kg for 10 days in mouse | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 9. | ALA838488 | A | Half life of compound after peroral administration at dose of 100 mg/kg for 1 day in rats | Rattus norvegicus | 1 | organism-based format | Scientific Literature | ||
| 10. | ALA838884 | A | Half life of compound after peroral administration at dose of 100 mg/kg for 7 days in rats | Rattus norvegicus | 1 | organism-based format | Scientific Literature | ||
| 11. | ALA838946 | A | Half life of compound after peroral administration at dose of 80 mg/kg for 10 days in mouse | Mus musculus | 2 | organism-based format | Scientific Literature | ||
| 12. | ALA839909 | A | Half life of compound after intravenous administration at dose of 80 mg/kg for 10 days in mouse | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 13. | ALA830487 | F | Mean graph mid point value for cytotoxic activity against human cancer cell lines was determined | Homo sapiens | 4 | cell-based format | Scientific Literature | ||
| 14. | ALA824913 | F | Growth inhibitory activity against human colon HT-29 cell line | Homo sapiens | 4 | cell-based format | Scientific Literature | ||
| 15. | ALA836362 | F | Growth inhibitory activity against human breast MCF-7 cell line | Homo sapiens | 4 | cell-based format | Scientific Literature | ||
| 16. | ALA836363 | F | Growth inhibitory activity against human colon SW620 cell line | Homo sapiens | 4 | cell-based format | Scientific Literature | ||
| 17. | ALA836368 | F | Growth inhibitory activity against human colon HCT116 cell line | Homo sapiens | 4 | cell-based format | Scientific Literature | ||
| 18. | ALA825888 | F | Growth inhibitory activity against human lung NCI-H522 cell line | Homo sapiens | 4 | cell-based format | Scientific Literature | ||
| 19. | ALA836373 | F | Growth inhibitory activity against human renal RXF-393 cell line | Homo sapiens | 4 | cell-based format | Scientific Literature | ||
| 20. | ALA836398 | F | Growth inhibitory activity against human leukemia HL-60 (TB) cell line | Homo sapiens | 4 | cell-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!